Cited by 1,193Health Promotion and Cardiovascular PreventionCardiovascular Health and Risk FactorsLipoproteins and Cardiovascular Health

The DOI matches its Crossref record; 280 of the 286 references it cites were found in a registry or an index.

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

Open access

Arnett, Donna K., Blumenthal, Roger S., Albert, Michelle A., Buroker, Andrew B., Goldberger, Zachary D., Hahn, Ellen J., Himmelfarb, Cheryl Dennison, Khera, Amit, Lloyd-Jones, Donald, McEvoy, J. William, Michos, Erin D., Miedema, Michael D., Muñoz, Daniel, Smith, Sidney C., Virani, Salim S., Williams, Kim A., Yeboah, Joseph, Ziaeian, Boback·2019·Journal of the American College of Cardiology

DOI 10.1016/j.jacc.2019.03.009PMC PMC8344373

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2019.03.009

Cites

280 of 280 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citation

Show all 286 references

Research works printed but not linked: 13

DeFilippis, 2017, Eur Heart J, 38, 598
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print]. · DOI
Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018 Nov 10 [E-pub ahead of print]. · DOI
Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646 · DOI · Paper page
Mortensen, 2016, A simple disease-guided approach to personalize ACC/AHA-recommended statin allocation in elderly people: the BioImage Study, J Am Coll Cardiol, 68, 881, 10.1016/j.jacc.2016.05.084 · DOI
Nasir, 2015, Implications of coronary artery calcium testing among statin candidates according to American College of Cardiology/American Heart Association cholesterol management guidelines: MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 66, 1657, 10.1016/j.jacc.2015.07.066 · DOI
Yano, 2017, Association of coronary artery calcium score vs age with cardiovascular risk in older adults: an analysis of pooled population-based studies, JAMA Cardiol, 2, 986, 10.1001/jamacardio.2017.2498 · DOI
Budoff, 2018, Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA), Eur Heart J, 39, 2401, 10.1093/eurheartj/ehy217 · DOI · Paper page
Whelton, 2018, J Am Coll Cardiol, 71, e127, 10.1016/j.jacc.2017.11.006 · DOI · Paper page
Sacks, 2001, Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group, N Engl J Med, 344, 3, 10.1056/NEJM200101043440101 · DOI · Paper page
Bress, 2017, Cost-effectiveness of intensive versus standard blood-pressure control, N Engl J Med, 377, 745, 10.1056/NEJMsa1616035 · DOI
Patnode, 2015, Behavioral counseling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the U.S. Preventive Services Task Force, Ann Intern Med, 163, 608, 10.7326/M15-0171 · DOI · Paper page
Guirguis-Blake, 2016, Aspirin for the primary prevention of cardiovascular events: a systematic evidence review for the U.S. Preventive Services Task Force, Ann Intern Med, 164, 804, 10.7326/M15-2113 · DOI

Sorted by citations

Items 801–900 of 1,000

Subacute effects of the number of Pilates exercise series on cardiovascular responses in hypertensive women
Chagas, J. C., Miguel‐dos‐Santos, R., Bastos, A. D. A., de Oliveira, E. D., Santana‐Filho, V. J., & Wichi, R. B. (2020) · Motriz Revista de Educação Física · doi:10.1590/s1980-6574202000030140 · Cited by 3
The Role of Biomarkers and Imaging to Predict Preeclampsia and Subsequent Cardiovascular Dysfunction
Woldu, B., Shah, L. M., Shaddeau, A., Goerlich, E., Zakaria, S., Hays, A. G., Vaught, A. “. J., Creanga, A. A., Blumenthal, R. S., & Sharma, G. V. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00913-6 · Cited by 3
Self-citation
Predicting Sensitivity to Adverse Lifestyle Risk Factors for Cardiometabolic Morbidity and Mortality
Pomares‐Millan, H., Poveda, A., Atabaki‐Pasdar, N., Johansson, I., Björk, J., Ohlsson, M., Giordano, G. N., & Franks, P. W. (2022) · Nutrients · doi:10.3390/nu14153171 · Cited by 3
Do statins benefit low-risk population for primary prevention of atherosclerotic cardiovascular disease: A retrospective cohort study
Ryou, I. S., Kim, J. Y., Park, H. Y., Oh, S., Kim, S., & Kim, H. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1024780 · Cited by 3
Long-Term Left Ventricular Remodeling After Hypertensive Disorders of Pregnancy
Davis, M. B. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.01.006 · Cited by 3
Too Much, Too Little, Too Late
Fry, E. T. A. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.01.007 · Cited by 3
Sex-Specific Mortality Benefits Related to Exercise
Jaber, W. A., & Hutt, E. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.01.003 · Cited by 3
Haptoglobin polymorphism, vitamin E and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
Delgado, G., Kleber, M. E., Moissl, A. P., Winklhofer‐Roob, B. M., Krämer, B. K., Renner, W., Langsenlehner, T., Dschietzig, T. B., März, W., & Armbruster, F. P. (2024) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2024-001061 · Cited by 2
“30 31 Some reports even reported an increased mortality risk associated with vitamin E supplementation 32 and excessive supplementation may lead to vitamin E toxicity, most notably manifested by an increased risk of bleeding.”
AVP-AP: Self-Supervised Automatic View Positioning in 3D Cardiac CT via Atlas Prompting
Fan, X., Wang, Y., Zhang, Y., Bao, M., Jia, B., Dong, L., Gu, Y., Cheng, J., & Zhu, H. (2025) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2025.3554785 · Cited by 2
“C ARDIOVASCULAR diseases (CVDs) are the leading cause of global mortality, resulting in up to 17.9 million deaths annually, representing 32% of the total global deaths [1], [2].”
Influential
Long-term outcomes of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a retrospective study from a tertiary care center in Saudi Arabia
Aldalaan, H., Alsagheir, A., Alghamdi, N. M., Alhuthil, R. T., Almslam, M. S., & Al‐Hamed, M. H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1512161 · Cited by 2
Multidisciplinary approach and combination pharmacotherapy for the management of cardiometabolic patients
Rosano, G. M. C., Vitale, C., Spoletini, I., Khunti, K. K., Tsioufis, K., Onida, S., Papaluca, M., & Zambon, A. (2025) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001734 · Cited by 2
Changes to the serum lipidome and their relation to coronary plaque in the first six months after acute myocardial infarction
White, J. B., Lin, A., Montarello, N. J., Bursill, C. A., Figtree, G. A., Dey, D., Snel, M. F., Verjans, J. W. H., Wong, D. T. L., & Psaltis, P. J. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120421 · Cited by 3
Moderating effects of a healthy lifestyle on the association of pre-metabolic syndrome with multiple chronic disease comorbidities
Xu, Y., Zhang, X., Fang, J., Xu, W., Chen, Q., Zhu, Y., Hu, H., Cao, X., & Zhang, X. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1652015 · Cited by 2
Impact of PREVENT Cardiovascular Risk Equations on Statin Eligibility by Subgroup and Risk Thresholds: A Cross-Sectional Study
Wright, A. P., McCoy, A. B., Garcia, K., Embí, P. J., Clair, W. K., Linton, M. F., & Wright, A. T. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09858-z · Cited by 2
The association of coronary artery disease by coronary CT angiography & cardiovascular outcomes in Psoriatic disease
Aun, J. A., Huck, D. M., Besser, S. A., Shiyovich, A., Petranović, M., Berman, A. N., Blair, C. V., Kotanidis, C. P., Hainer, J. M., Biery, D. W., et al. (2025) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101317 · Cited by 2
Dual modulation of atherosclerosis by exercise and metformin: convergent pathways, divergent outcomes, and therapeutic potential
Li, H., Zhang, Z., Sun, M., & Xu, S. (2025) · Clinical Hypertension · doi:10.5646/ch.2025.31.e34 · Cited by 2
“…to counteract the deleterious effects of sedentary behavior—a leading global risk factor for cardiovascular disease (CVD) and all-cause mortality [8,9], Sedentary time, particularly screen-based and deskbound activities expending less than 1.5 metabolic equivalent of tasks, is independently…”
Influential
Association Between Serum Micronutrients and Advanced CKM Syndrome: An Interpretable Machine Learning‐Based Study
Ou, Y., Shao, X., Fu, Y., Qu, X., Zhan, Y., Liu, Q., Chen, J., Chen, A., Bai, G., & Zhang, J. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.71059 · Cited by 2
“Li (2023) reported that low vitamin C status was associated with a higher risk of CKD. Additionally, a recent investigation demonstrated that elevated serum lycopene levels are significantly associated with a reduced risk of mortality from all causes and CVD among patients with CKD (Zhong et al. 2022).”
Influential
Coronary Artery Calcium (CAC) Imaging as a Diagnostic Test
Naghavi, M., Wong, N. D., McConnell, M. V., Maron, D. J., Nasir, K., Henschke, C. I., Yankelevitz, D. F., Fayad, Z. A., Vliegenthart, R., Williams, K. A., Sr., et al. (2025) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2025.10.020 · Cited by 2
A laboratory-driven clinical decision support system algorithm for personalized and automated cardiovascular risk stratification in primary care patients.
Tortosa-Carreres, J., Piqueras, M., Cátedra, C., Vañó-Bellver, A., Domingo, D., Claramunt-Carbonell, T., Martínez-Dolz, L., & Laiz-Marro, B. (2026) · Clinica Chimica Acta · doi:10.1016/j.cca.2026.120943 · Cited by 2
Prognostic Value of Serum Lipoprotein(a) Levels in Japanese Patients With ST-Segment Elevation Myocardial Infarction
Nishiyama, K., Nishihira, K., Nakai, M., Baba, K., Takamatsu, M., Honda, Y., Yamamoto, K., Nishino, S., Kadooka, K., Kudo, T., et al. (2026) · Circulation Journal · doi:10.1253/circj.cj-25-0889 · Cited by 3
Combining Genomics With Lipid and Inflammatory Biomarkers to Predict Coronary Artery Disease Risk
Farah, R., Kim, M. S., Truong, B. M. T., Sui, Y., Cho, S. M. J., Urbut, S., Patel, A. P., Ridker, P. M., Natarajan, P., & Fahed, A. C. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.01.076 · Cited by 2
Incremental prognostic value of coronary artery calcium progression within a large community-benefit calcium score registry
Glidden, M. D., Sirasapalli, S. K., Yoder, M., Dazard, J.-E., Chen, Z., Ponnana, S. R., Sivanantham, K., Hassani, N. S., Zhang, T., Parameswaran, G., et al. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2026.101553 · Cited by 2
“The American College of Cardiology/American Heart Association (ACC/AHA) and European Society of Cardiology (ESC) both suggest a “ warranty period ” [12] for those with a baseline score of zero, recommending a repeat scan in 5 – 10 years, particularly if statin therapy was not initiated [13,14].”
Navigating Medication Risk in the ED : Communication Preferences of Older Adults Regarding Deprescribing
Burud, G. A., Lopes, E., Bhimani, S. R., Goyal, P., Niznik, J. D., Donvan, K., Dodson, A., Musgrow, K., Anton, G., Hwang, U., et al. (2026) · Academic Emergency Medicine · doi:10.1111/acem.70287 · Cited by 2
“One common potentially inappropriate medication is aspirin, an antiplatelet, that continues to be prescribed for primary prevention against cardiovascular disease, despite recent guidelines stating anticipated harms outweigh benefits [9, 10].”
The role of primary care in response to the global liver disease syndemic: a Lancet Gastroenterology & Hepatology Commission
Jarvis, H., Brennan, P., Casanovas, T., Casler, K., Desai, M., Evans, P. H., Dillon, J. F., Grattagliano, I., Hallsworth, K., Hebditch, V., et al. (2026) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(26)00015-4 · Cited by 3
Papel de la Aspirina® como tratamiento antiagregante en prevención primaria. Puesta al día
Jiménez-García, N., Lima, J. D. L. T., & Alegría, J. G. (2019) · Medicina Clínica · doi:10.1016/j.medcli.2019.05.024 · Cited by 3
Prevalencia de prescripción del ácido acetilsalicílico a dosis bajas en prevención primaria en población española, evolución temporal y factores asociados
Rodríguez‐Martín, S., García‐Lledó, A., Gil, M., Barreira‐Hernández, D., Rodríguez, A., & de Abajo, F. J. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2019.10.012 · Cited by 2
Risk of Atherosclerotic Cardiovascular Diseases in various Ethnicities of Pakistan
Ashraf, T., Nadeem, A., Sarwar, S., & Karim, M. (2020) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.6.2618 · Cited by 2
A randomized trial of a brief behavioral health lifestyle program for outpatient cardiology clinics
Wiener, C. H., Cassisi, J. E., Blaney, C. L., Newins, A. R., & Gros, B. J. (2020) · Journal of Health Psychology · doi:10.1177/1359105320945003 · Cited by 2
“Lifestyle changes in areas such as healthy eating, physical activity, weight management, stress management, and smoking cessation are essential for both the management (e.g. Fihn et al., 2012) and prevention (e.g. Arnett et al., 2019) of cardiovascular disease.”
Background
Relationship Between Metabolic Syndrome and the Brazilian Workers’ Food Program in Male and Female Manufacturing Workers
Pereira, G. S., Bezerra, I. W. L., de Souza, A. M., dos Santos, I. C. C., Silbiger, V. N., Costa, R. M., Torres, K. G., & Oliveira, A. G. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s264181 · Cited by 2
Saudi Arabian Consensus Statement on Vagus Nerve Stimulation for Refractory Epilepsy
Alqadi, K. S., Aldhalaan, H., Alghamdi, A., Bamgadam, F., Abu-jabber, A., Baeesa, S. S., Althubaiti, I., & Baz, S. (2020) · Saudi Journal of Medicine and Medical Sciences · doi:10.4103/sjmms.sjmms_578_19 · Cited by 2
Racial/Ethnic Considerations in the Prevention of Cardiovascular Disease
Ferdinand, K. C., Ali, A., & Echols, M. R. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56279-3_20 · Cited by 2
Effect of More Intensive LDL-C–Lowering Therapy on Long-term Cardiovascular Outcomes in Early-Phase Acute Coronary Syndrome: A Systematic Review and Meta-analysis
Jin, S., Nie, X., Li, Y., Yuan, J., Cui, Y., & Zhao, L. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.04.019 · Cited by 2
Aortic stiffness and content of adipokines in the serum in persons of European and South Asian ethnic
Brodskaya, T. A., Ивановна, Р. Н., Афанасьевна, Н. В., Плехова, Н. Г., & Shumatov, V. B. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.04.200679 · Cited by 2
The Influence of Family History of Ischemic Heart Disease on Healthy Behaviors
Kim, S., Lee, B., Oh, S., Lee, D., Kim, S., & Ko, Y.-J. (2022) · Korean Journal of Family Practice · doi:10.21215/kjfp.2022.12.1.16 · Cited by 2
Screening for Public Purpose: Promoting an Evidence-Based Approach to Screening of Inmates to Improve Public Health
Nagami, E. H., Rich, J. D., & Lee, J. D. (2021) · Springer eBooks · doi:10.1007/978-1-0716-1807-3_15 · Cited by 2
Participation in a food assistance program and excessive weight gain: an evaluation of the Brazilian Worker’s Food Program in male and female manufacturing workers
Costa, R. M., Bezerra, I. W. L., Torres, K. G., Pereira, G. S., de Souza, A. M., & Oliveira, A. G. (2022) · BMC Public Health · doi:10.1186/s12889-022-13447-8 · Cited by 2
Association of country economy and socioeconomic factors on risk factor control for primary prevention of cardiovascular disease in patients with diabetes mellitus: Insights from the DISCOVER study
Malik, A. O., Chen, H., Tang, F., Chan, P. S., Cooper, A., Gomes, M. B., Hejjaji, V., Ji, L., Khunti, K., Kosiborod, M., et al. (2022) · Indian Heart Journal · doi:10.1016/j.ihj.2022.07.008 · Cited by 2
Assessing Performance of Martins’s and Sampson’s Formulae for Calculation of LDL-C in Indian Population: A Single Center Retrospective Study
Sankanagoudar, S., Tomo, S., Syiemlieh, A., Sharma, P. P., Banerjee, M., & Sharma, P. (2023) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-023-01142-3 · Cited by 2
Development of Artificial Intelligence Algorithms to Analyse Weather Conditions for the Prediction of Cerebrovascular Accidents
Kwiatkowski, A., Sobolewski, O., Wyłomańska, A., Sawicki, M., Zieleń, P., Druszcz, A., & Ptak, M. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-34884-6_16 · Cited by 2
Prevalence, patterns and associated risk factors for dyslipidaemia among individuals attending the diabetes clinic at a tertiary hospital in Central Malawi
Filisa-Kaphamtengo, F., Ngoma, J., Mukhula, V. T., Matemvu, Z., Kapute, D., Banda, P., Phiri, T., Mipando, M., Hosseinipour, M. C., & Katundu, K. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03589-x · Cited by 2
Diet and Lifestyle Intervention-Induced Pattern of Weight Loss Related to Reduction in Low-Attenuation Coronary Plaque Burden
Henzel, J., Kruk, M. B. P., Kępka, C., Makarewicz‐Wujec, M., Wardziak, Ł., Trochimiuk, P., Krysztofiak, H., Dąbrowski, R., Dzielińska, Z., Maurovich‐Horvat, P., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14060615 · Cited by 2
Healthcare systems collaborating to implement a shared decision‐making tool in the electronic health record and build evidence on its adoption and use
Branda, M. E., Ridgeway, J. L., Mann, D., Wieser, J., Gomez, Y. L., Dagoberg, A., Nautiyal, V., Jackson, H., Jahn, P., Yaple, K., et al. (2024) · Learning Health Systems · doi:10.1002/lrh2.10418 · Cited by 2
Clinician Perceptions on Using Decision Tools to Support Prediction-Based Shared Decision Making for Lung Cancer Screening
Skurla, S. E., Leishman, N. J., Fagerlin, A., Wiener, R. S., Lowery, J. C., & Caverly, T. J. (2024) · MDM Policy & Practice · doi:10.1177/23814683241252786 · Cited by 2
Optimal risk thresholds for prescribing statins as primary prevention of cardiovascular disease in Iranian general population: a benefit-harm modelling study
Khalili, D., Saadati, H., Baradaran, H. R., Hadaegh, F., Steyerberg, E. W., Woodward, M., & Danaei, G. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04242-x · Cited by 2
Development of an Initial Screening Scale to Detect Patients With Chest Pain From Acute Coronary Syndrome in the Emergency Department
Jang, K., & Choe, K. (2024) · Journal of Clinical Nursing · doi:10.1111/jocn.17506 · Cited by 2
Prevalence of traditional cardiovascular risk factors in high-risk Kyrgyzstan population as compared to Indians − An Indo-Kyrgyz cardiometabolic study
Sharma, K. H., Mohan, S. C., Hossain, S. A., Shah, S., Konat, A. R., Shah, K., Mehta, S., Tavethia, J., Sarvaiya, J. N., Joshi, S., et al. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_712_24 · Cited by 2
Explaining the Variance in Cardiovascular Health Indicators among Asian Americans: A Comparison of Demographic, Socioeconomic, and Ethnicity
Sevillano, L., Bacong, A. M., & Maglalang, D. D. (2025) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-025-02341-9 · Cited by 2
Area-level socioeconomic inequalities in hypertension care cascade in China: a nationwide population-based study based on the ChinaHEART project
Peng, W., Lin, S., Liu, X., Chen, B., Bai, X., Wu, C., Zhang, X., Yang, Y., Cui, J., Xu, W., et al. (2025) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2025.101544 · Cited by 2
Delphi consensus statement for the management of delayed post-polypectomy bleeding
de Santiago, E. R., de la Iglesia, S. P., Rosa, D. D. F., Marín-Gabriel, J. C., Mangas‐Sanjuán, C., López, R. H., Uchima, H., Aicart‐Ramos, M., Rodríguez-Gandía, M. Á., Cortázar, E. V., et al. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251329145 · Cited by 2
Racial and Ethnic Differences in Shared Decision Making Among Patients With Hypertension: Results From the RICH LIFE Project
Elias, S. D., Cooper, L. A., Commodore-Mensah, Y. Y., Perrin, N., Lewis, K. B., Koirala, B., Wenzel, J. A., Slone, S., Turkson‐Ocran, R., Ogungbe, O., et al. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.036664 · Cited by 2
Self-citation
Joint and independent associations of dietary vitamin intake and prevalence of cardiovascular disease in chronic kidney disease subjects: a cross-sectional analysis
Wang, G., Huang, L., Yue, W., & Jun, F. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1579313 · Cited by 2
Association between non-alcoholic fatty liver disease and arterial stiffness measured by brachial-ankle pulse wave velocity: a cross-sectional population study
Wang, Y., Fang, Z., Fu, Q., Yao, D., & Jin, X. (2025) · PeerJ · doi:10.7717/peerj.19405 · Cited by 2
“…College of Cardiology (ACC) clinical practice guidelines recommending appropriate calibration of the 10-year ASCVD risk estimator, NAFLD may potentially be validated as a risk-enhancing factor for adults in the intermediate-risk category (5 − 7.5% 10-year ASCVD risk) ( Arnett et al., 2019 ).”
Influential
Deep learning image reconstruction and adaptive statistical iterative reconstruction on coronary artery calcium scoring in high risk population for coronary heart disease
Zhu, L., Shi, X., Tang, L., Machida, H., Yang, L., Ma, M., Ha, R., Shen, Y., Wang, F., & Chen, D. (2025) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-025-03049-w · Cited by 2
Association of Cardiovascular Health and Time Lived With Zero Coronary Artery Calcium
Shah, N. S., Huang, X., Cameron, N. A., Petito, L. C., Zhou, B., Allen, N. B., Carnethon, M. R., Greenland, P., Lloyd‐Jones, D. M., & Khan, S. S. (2025) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2025.05.022 · Cited by 2
Self-citation
Sex differences in mortality associated with physical activity before and after acute coronary syndrome
Jae, S. Y., Cho, D., Kunutsor, S. K., Choi, J., Franklin, B. A., & Gwon, J. G. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120559 · Cited by 2
An Assessment of Training Characteristics Associated with Atrial Fibrillation in Masters Runners
Matsumura, M. E., & Abbatemarco, J. (2019) · Sports · doi:10.3390/sports7070179 · Cited by 2
ST-Segment Elevation Myocardial Infarction 2 h After Zero Calcium Score
Corrigan, F. E. (2020) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2019.11.037 · Cited by 2
Managed care pharmacist updates for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors
Patel, J. (2021) · The American Journal of Managed Care · doi:10.37765/ajmc.2021.88608 · Cited by 2
Levels of high‑sensitivity C‑reactive protein in young and middle‑aged individuals and their association with hypertension
Polyakova, O. A., Kirichenko, A. A., & Анатольевич, Б. И. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-1-44-48 · Cited by 2
Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort Study
Sun, S.-H., Chang, C., Zhan, Z.-W., Chang, W.-H., Chen, Y., & Dong, Y. (2021) · International Journal of COPD · doi:10.2147/copd.s323391 · Cited by 2
Cardiovascular patients
Papadakis, S., Pipe, A., Vlachopoulos, C. V., Ioakeimidis, N., & Katsaounou, P. (2021) · European Respiratory Society eBooks · doi:10.1183/2312508x.10003120 · Cited by 2
The role of aspirin as antiaggregant therapy in primary prevention. An update
Jiménez-García, N., Lima, J. D. L. T., & Alegría, J. G. (2019) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2019.05.005 · Cited by 2
Development and Internal Validation of A Prediction Tool To Assist Clinicians Selecting Second-Line Therapy Following Metformin Monotherapy For Type 2 Diabetes
Sanadi, C. E. E., Pantalone, K. M., Ji, X., & Kattan, M. W. (2020) · Endocrine Practice · doi:10.1016/j.eprac.2020.10.015 · Cited by 2
Antifibrotic Effect of a Novel Selective 11β-HSD2 Inhibitor (WZ51) in a rat Model of Myocardial Fibrosis
Zhuang, F., Ge, Q., Qian, J., Wang, Z., Dong, Y., Chen, M., Zhang, X., & Sun, W. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.629818 · Cited by 2
“With the global aging population, cardiovascular disease has become an important cause of disability and even death (Arnett et al., 2019).”
Background
The Future of Women and Heart Disease in a Pandemic Era: Let’s Learn from the Past
Steinbaum, S. (2021) · Medicina · doi:10.3390/medicina57050467 · Cited by 2
Development, Implementation, and Evaluation of an Educational Package to Control the Biomedical Profile of Metabolic Syndrome
Aein, A., Omidi, N., Khatami, F., Samat, S., & Khorgami, M. (2021) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_434_20 · Cited by 2
Coronary risk reduction intervention for siblings and offspring of patients with premature coronary heart disease: the CRISO study protocol for a randomised controlled pilot study
Mifsud, J. L., Stephenson, J. R., Astin, F., & Galea, J. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00874-4 · Cited by 3
Dietary and Lifestyle Cardiometabolic Risk Reduction Strategies in Pro-inflammatory Diseases
Blazer, A., Parikh, K. H., Fudman, D. I., & Garshick, M. S. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-78177-4_12 · Cited by 2
Cardiovascular risk in immune-mediated inflammatory diseases
Barrera‐Ochoa, C. A., Berná‐Rico, E., Burgos‐Blasco, P., Saceda‐Corralo, D., & Gonz�lez-Cantero, �. (2021) · Journal of IMIDs · doi:10.24875/jimids.m21000004 · Cited by 2
Noninvasive Imaging for the Asymptomatic Patient
Logan, J. K., & Ayers, M. P. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.11.012 · Cited by 2
Clinical strategies for reducing cholesterol levels
Lardinois, C. K., & Karr, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85857-1.00027-4 · Cited by 2
Cardioprotection of High-Risk Individuals
Upshaw, J. N., Mohanty, S., & Rastogi, A. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.02.001 · Cited by 2
Cardiodiabetology: newer pharmacologic strategies for reducing cardiovascular disease risks
Wong, N. D. (2022) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2022-0065 · Cited by 2
The role of coronary computed tomography angiography in low- and intermediate-risk patients with chest pain: a paradigm shift in modern cardiology
Harfi, T. T., Raman, S. V., & Cardona, A. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03214-x · Cited by 2
Subdural hygroma and hemorrhagic conversion after microsurgical clipping for unruptured intracranial aneurysm
Han, H. J., Kim, J., Park, K. Y., Park, S. K., Chung, J., & Kim, Y. B. (2023) · Acta Neurochirurgica · doi:10.1007/s00701-023-05555-0 · Cited by 3
The Role of RNA Interference Therapeutics in Hypercholesterolemia and Implications for Practice
DePhillips, C. (2023) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2023.104619 · Cited by 2
From guidelines to decision aids and adherence supports: Insights from the process of evidence translation
Sheridan, S. (2023) · Patient Education and Counseling · doi:10.1016/j.pec.2023.107806 · Cited by 2
Blood pressure measurement campaign (May Measurement Month) 2019: Analysis of screening in spanish community pharmacies and detection of masked hypertensionPercepción del farmacéutico sobre su actuación e implicación profesional en la dispensación y entrega gratuita a la población de la Comunidad de Madrid de test de antígenos de autodiagnóstico de Covid-19
Mera-Gallego, I., Tous, S., Más, R. P., Molinero, A., Fornos-Pérez, J. A., & Rodríguez, N. F. A. (2023) · Farmacéuticos Comunitarios · doi:10.33620/fc.2173-9218.(2023).27 · Cited by 2
Biomarkers and Imaging Modalities to Detect Subclinical Atherosclerotic Cardiovascular Disease
McNeal, C. J., Houck, P. D., Nguyen, N. N., Murchison, J. A., & Chiang, H. (2024) · Contemporary cardiology · doi:10.1007/978-3-031-54960-1_4 · Cited by 2
Association between statin intensity and femoropopliteal stent primary patency in peripheral arterial disease
Seyferth, E. R., Song, H., Vance, A. Z., & Clark, T. W. I. (2024) · CVIR Endovascular · doi:10.1186/s42155-024-00472-4 · Cited by 2
Is There Equipoise Regarding the Optimal Medical Treatment of Patients with Asymptomatic White Matter Hyperintensities?
de Havenon, A., Prabhakaran, S., Turan, T. N., Gottesman, R. F., Yeatts, S. D., & Rost, N. S. (2019) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2019.104371 · Cited by 2
Carotid Plaque Burden by 3-Dimensional Vascular Ultrasound as a Risk Marker for Patients with Metabolic Syndrome
López‐Melgar, B., Varona, J. F., Ortiz-Regalón, R., Sánchez‐Vera, I., Díaz, B., Castellano, J. M., Jiménez, F. J., & Fernández‐Friera, L. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10121-z · Cited by 2
Validation of the Martin method to estimate low-density lipoprotein cholesterol concentrations in Japanese populations and a modified method for laboratory information system application
Ishida, H., Yamamoto, Y., Saito, M., Ishihara, Y., Fujita, T., Ishida, M., Kato, Y., Nohisa, Y., Matsunami, H., Takemura, M., et al. (2022) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632221098870 · Cited by 2
The death of aspirin for primary prevention—should aspirin be changed to a prescription only medication?
Rawal, A., Cave, B. E., Ardeshna, D. R., Hana, D., Ibebuogu, U. N., & Khouzam, R. N. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.07.05 · Cited by 2
How to re-style your life
Gori, T., & Rakhimov, K. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319876232 · Cited by 2
Do we really need more new biomarkers for cardiovascular risk prediction?
Nilsson, P. M. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319893050 · Cited by 2
Preventive cardiology or cardiometabolic medicine: a new and emerging subspecialty?
Wong, N. D. (2020) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000206 · Cited by 2
An update on genetic risk scores for coronary artery disease: are they useful for predicting disease risk and guiding clinical decisions?
Lieb, W., & Vasan, R. S. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1797489 · Cited by 2
Dose-dependent effect of nuts on blood pressure: a systematic review and meta-analysis of randomized controlled trialsPreprint
Jayedi, A., Khan, T. A., Mirrafiei, A., Ganjeh, B. J., Hosseini, Y., Zeraattalab-Motlagh, S., Jibril, A. T., Shahinfar, H., & Shab‐Bidar, S. (2021) · medRxiv · doi:10.1101/2021.05.21.21257564 · Cited by 2
Coronary Artery Calcium
Budoff, M. J. (2021) · JACC Asia · doi:10.1016/j.jacasi.2021.05.007 · Cited by 2
Coronary Artery Calcium and Chest Pain
Hecht, H. S. (2022) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2022.05.023 · Cited by 2
Can carotid plaque assessment perform the role of a risk predictor for secondary prevention?
Osawa, K. (2023) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.02.023 · Cited by 2
The Impact of Social Determinants of Health and Lifestyle on the Association of Lipoprotein(a) with Myocardial Infarction and StrokePreprint
Brandt, E. J., Kirch, M., Patel, N., Chennareddy, C., Murthy, V. L., & Goonewardena, S. N. (2023) · medRxiv · doi:10.1101/2023.09.01.23294968 · Cited by 2
Outcomes of TAVR in Minimally Symptomatic Aortic Stenosis
Rihal, C. S. (2023) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2023.08.020 · Cited by 2
Agent-Based Modeling to Examine Patient Behavior Within a Social Network
Phillips, A. B., Sordo, M., & Wood, L. J. (2020) · CIN Computers Informatics Nursing · doi:10.1097/cin.0000000000000700 · Cited by 1
The Body Fat Percentage Rather Than the BMI Is Associated with the CD4 Count among HIV Positive Japanese Individuals
Shoji, K., Shirano, M., Konishi, M., Toyoshima, Y., Matsumoto, M., Goto, T., Kasamatsu, Y., Ichida, Y., Kagawa, Y., Kawabata, T., et al. (2022) · Nutrients · doi:10.3390/nu14030428 · Cited by 1
Low-dose aspirin for the prevention of atherothrombosis across the cardiovascular risk continuum
Walker, J. (2022) · Cardiology Plus · doi:10.1097/cp9.0000000000000017 · Cited by 1
Is Alcohol Consumption Associated with a Lower Risk of Cardiovascular Events in Patients Treated with Statins? An Observational Real-World Experience
Anderson, J. L., Le, V. T., Bair, T. L., Muhlestein, J. B., Knowlton, K. U., & Horne, B. D. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164797 · Cited by 1
Smartphone-enabled retinal arteriovenous imaging and correlation with coronary SYNTAX score
Ambaliya, H. C., Gupta, R., Chahar, C., Tyagi, L., Chaturvedi, H., & Khedar, R. S. (2022) · Indian Heart Journal · doi:10.1016/j.ihj.2022.11.005 · Cited by 1
Preclinical Study on a Novel Fluoroderivative of Dabigatran Etexilate in Animal Models
Ren, Y., Li, C., & Zhang, Y. (2023) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001493 · Cited by 1

Authors: Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., Michos, E. D., Miedema, M. D., Muñoz, D., Smith, S. C., Virani, S. S., Williams, K. A., Yeboah, J., & Ziaeian, B.
ORCID: Arnett, Donna K.
Blumenthal, Roger S.
Albert, Michelle A.
Goldberger, Zachary D.
Hahn, Ellen J.
Himmelfarb, Cheryl Dennison
Khera, Amit
McEvoy, J. William
Michos, Erin D.
Miedema, Michael D.
Virani, Salim S.
Williams, Kim A.
Yeboah, Joseph
Ziaeian, Boback
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 2019-09
Volume: 74
Issue: 10
Pages: 1376-1414
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/j.jacc.2019.03.009
PMC: PMC8344373
OpenAlex: W2984766121
Cited by: 1,193
References: 286
Citations by year: 2026: 87 · 2025: 140 · 2024: 131 · 2023: 167 · 2022: 191 · 2021: 207 · 2020: 191 · 2019: 79
FWCI: 153.80
Type: journal article
Language: en
Update notices: erratum (2020-02-25)
erratum (2019-09-10)
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 375 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: American Heart Association (17SDG33630113)
National Institutes of Health (KL2TR001882)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Keywords: primary prevention, cardiovascular disease, cardiovascular risk factors, cardiovascular disease prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks